Physician profile
Mark A Ludwig
NPI 1841220498
$1,047.07
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.21 · 2020: $289 · 2021: $87.34 · 2022: $231 · 2023: $334 · 2024: $42.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $493.61 | 2020-2024 | Puraply Antimicrobial, Puraply |
| Smith+Nephew, INC. | $230.53 | 2019-2024 | Grafix Pl, Regranex, Collagenase Santyl |
| Acera Surgical, INC. | $116.36 | 2022-2023 | Restrata Wound Matrix |
| Hydrofera LLC | $42.64 | 2022-2023 | Hydrofera Blue |
| Kerecis Limited | $33.36 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Ovik Health, LLC | $24.85 | 2023 | |
| Misonix INC | $23.81 | 2020-2021 | |
| Aroa Biosurgery Incorporated | $22.34 | 2019 | |
| Celularity INC. | $19.00 | 2019 | |
| Kci USA, INC. | $15.22 | 2020 | |
| Integra Lifesciences Corporation | $14.35 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Tactile Systems Technology INC | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Ludwig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.